Medikit CoTSE:7749 -0.18%80 Net Margin % is 13.54% as of Dec. 2025, which is 3% below its 10-year median of 13.99. GuruFocus rates TSE:7749 with a GF Score™ of 80/100 and a GF Value™ of 円3,281.26 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Medikit Co ranks better than 78.7% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Medikit Co's Net Income for the
three
months ended in Dec. 2025 was 円886 Mil. Medikit Co's Revenue for the
three
months ended in Dec. 2025 was 円6,544 Mil. Therefore, Medikit Co's net margin for the quarter that ended in Dec. 2025 was 13.54%.
The historical rank and industry rank for Medikit Co's Net Margin % or its related term are showing as below:
TSE:7749'
s Net Margin % Range Over the Past 10 Years
Min: 12.64 Med: 13.99 Max: 14.87
Current: 12.64
TSE:7749's Net Margin % is ranked better than 78.7% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs TSE:7749: 12.64
Medikit Co (TSE:7749) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Medikit Co Net Margin % Related Terms
Medikit Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Medikit Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7749 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Medikit Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medikit Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medikit Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Medikit Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medikit Co (TSE:7749) has a Net Margin % of 13.54% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Medikit Co and its competitors. This is near median its historical median of 13.99. Over the past decade, Medikit Co's Net Margin % has ranged from 12.64 to 14.87. According to the industry distribution chart, Medikit Co ranks #174 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 21.3%.
Is Medikit Co's Net Margin % too high?
Medikit Co's current Net Margin % of 13.54% is near median its 10-year median of 13.99. Over the past 10 years, this metric has ranged from a low of 12.64 to a high of 14.87. The Medical Devices & Instruments industry median Net Margin % is 2.09. Medikit Co's value of 13.54% is 547.8% above this industry median. Based on the distribution chart, Medikit Co ranks #174 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medikit Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medikit Co's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medikit Co ranks #174 out of 817 companies for Net Margin %. This places Medikit Co in the top 21% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.09. Medikit Co's value of 13.54% is 547.8% above this benchmark. Historically, Medikit Co's own Net Margin % has ranged from 12.64 to 14.87 over the past decade. While the company's 10-year median is 13.99 vs. the industry median of 2.09, Medikit Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medikit Co's current Net Margin % of 13.54% is 547.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Medikit Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medikit Co's current Net Margin % is 13.54%, which is near median its own 10-year median of 13.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medikit Co stock overvalued right now?
Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,281.26, compared to a current price of 円2,805.00 — trading 14.5% below its estimated fair value. The current Net Margin % is 13.54%, which is near median its 10-year median of 13.99 and 547.8% above the Medical Devices & Instruments industry median of 2.09. Medikit Co's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current Net Margin % is 13.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medikit Co (TSE:7749) Overvalued in 2026?
Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued.
The current stock price of 円2,805.00 is trading 14.5% below its estimated GF Value™ of 円3,281.26.
GuruFocus considers Medikit Co to be Modestly Undervalued.
Key valuation signals for TSE:7749:
Net Margin %: 13.54% (near median its 10-year median of 13.99)
GF Value™: 円3,281.26 vs. price of 円2,805.00 (14.5% below fair value)
Industry Position: 547.8% above the Medical Devices & Instruments median (#174 of 817)
No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.
80GF Score
Get the complete analysis for TSE:7749
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7749 has been successfully added to your 
